We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Google Tests AI Algorithm to Help Detect Metastatic Breast Cancers

By HospiMedica International staff writers
Posted on 25 Oct 2018
Print article
Image: Left: sample view of a slide containing lymph nodes, with multiple artifacts: the dark zone on the left is an air bubble, the white streaks are cutting artifacts, the red hue across some regions are hemorrhagic (containing blood), the tissue is necrotic (decaying), and the processing quality was poor. Right: LYNA identifies the tumor region in the center (red), and correctly classifies the surrounding artifact-laden regions as non-tumor (blue) (Photo courtesy of Google AI).
Image: Left: sample view of a slide containing lymph nodes, with multiple artifacts: the dark zone on the left is an air bubble, the white streaks are cutting artifacts, the red hue across some regions are hemorrhagic (containing blood), the tissue is necrotic (decaying), and the processing quality was poor. Right: LYNA identifies the tumor region in the center (red), and correctly classifies the surrounding artifact-laden regions as non-tumor (blue) (Photo courtesy of Google AI).
Scientists at Google AI (Mountain View, CA, USA) who have been developing an algorithm to detect the spread of breast cancer have published new research showing its promise as an assistive tool for pathologists.

Google AI had described its deep learning–based approach to improve diagnostic accuracy (LYmph Node Assistant, or LYNA) to the 2016 ISBI Camelyon Challenge, which provides gigapixel-sized pathology slides of lymph nodes from breast cancer patients for researchers to develop computer algorithms to detect metastatic cancer. LYNA has achieved significantly higher cancer detection rates than had been previously reported. In their latest published studies, the scientists presented a proof-of-concept pathologist assistance tool based on LYNA and their investigation of these factors.

In the first paper, the scientists applied their algorithm to de-identified pathology slides from both the Camelyon Challenge and an independent dataset provided by our co-authors at the Naval Medical Center San Diego. This additional dataset consisted of pathology samples from a different lab using different processes, thereby improving the representation of the diversity of slides and artifacts seen in routine clinical practice. LYNA proved robust to image variability and numerous histological artifacts, and achieved similar performance on both datasets without additional development.

In both the datasets, LYNA was able to correctly distinguish a slide with metastatic cancer from a slide without cancer 99% of the time. Additionally, LYNA could accurately pinpoint the location of both cancers and other suspicious regions within each slide, some of which were too small to be consistently detected by pathologists. Based on this, the researchers believe that one potential benefit of LYNA could be to highlight these areas of concern for pathologists to review and determine the final diagnosis.

In their second paper, six board-certified pathologists completed a simulated diagnostic task in which they reviewed lymph nodes for metastatic breast cancer both with and without the assistance of LYNA. For the often-laborious task of detecting small metastases (termed micrometastases), the use of LYNA made the task subjectively “easier” (according to pathologists’ self-reported diagnostic difficulty) and halved average slide review time, requiring about one minute instead of two minutes per slide.

This indicates the intriguing potential for assistive technologies such as LYNA to reduce the burden of repetitive identification tasks and to allow more time and energy for pathologists to focus on other, more challenging clinical and diagnostic tasks. In terms of diagnostic accuracy, pathologists in this study were able to more reliably detect micrometastases with LYNA, reducing the rate of missed micrometastases by a factor of two. Encouragingly, pathologists with LYNA assistance were more accurate than either unassisted pathologists or the LYNA algorithm itself, indicating that people and algorithms can work together effectively to perform better than working independently.

Related Links:
Google AI

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.